Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/12/2026

Diagnostic and Management Guidelines for Primary Adrenal Insufficiency (Addison’s Disease)

1. Diagnostic Criteria

  • The 250 µg corticotropin (ACTH) stimulation test is the gold‑standard diagnostic tool; a peak serum cortisol < 500 nmol/L (18 µg/dL) confirms primary adrenal insufficiency. 1

2. Clinical Features Prompting Testing

  • Hyperpigmentation of sun‑exposed skin, creases, mucosa, scars, and areolae is specific to primary adrenal insufficiency because excess ACTH stimulates melanocytes. 1, 2
  • The combination of hyponatremia and hyperkalemia reflects concurrent cortisol and aldosterone deficiency and is a key laboratory clue. 1, 2
  • Cardiovascular manifestations include hypotension with an exaggerated orthostatic drop and signs of volume depletion. 1, 2
  • Constitutional symptoms such as unexplained weight loss, postural dizziness, anorexia, abdominal discomfort, and salt craving are common presentations. 1, 2
  • In pediatric patients, failure to thrive and hypoglycemia are important warning signs. 1, 2

3. Initial Screening When Immediate ACTH Test Is Unavailable

  • Morning (≈8 AM) plasma cortisol measurement assists screening; markedly low cortisol together with markedly elevated ACTH strongly suggests primary adrenal insufficiency. 1
  • Serum electrolytes should be checked for hyponatremia and hyperkalemia as supportive evidence. 1, 2
  • Random blood glucose may uncover hypoglycemia, especially in children. 1, 2

4. Confirmatory Testing Protocol

  • Perform the standard 250 µg synthetic ACTH (cosyntropin) stimulation test: obtain baseline cortisol and ACTH, administer the dose intravenously or intramuscularly, and measure cortisol at 30 min and 60 min. A peak cortisol < 500 nmol/L confirms the diagnosis. 1

5. Determining Underlying Etiology

  • Testing for 21‑hydroxylase (CYP21A2) autoantibodies identifies autoimmune adrenalitis, which accounts for up to 90 % of primary cases in Western populations. 1, 2
  • If autoantibodies are negative, abdominal imaging (CT) is recommended to evaluate for tuberculosis, neoplasms, infiltrative disease, or adrenal hemorrhage.
  • Genetic testing should be considered in children or when a familial pattern suggests inherited adrenal disorders. 1

6. Emergency Management of Adrenal Crisis

  • In suspected adrenal crisis, treatment must not be delayed for diagnostic confirmation; obtain blood for cortisol and ACTH before the first hydrocortisone dose, but initiate therapy immediately. 1
  • Immediate therapy consists of IV hydrocortisone 100 mg bolus followed by 50–100 mg every 6–8 h (or 200 mg continuous infusion over 24 h) together with aggressive isotonic saline resuscitation.
  • Common precipitants of crisis include volume depletion, severe hypotension, hyponatremia, hyperkalemia, fever, abdominal pain, hypoglycemia (especially in children), confusion, and syncope. 1, 2

7. Differentiating Primary from Secondary Adrenal Insufficiency

  • ACTH levels are markedly elevated in primary disease, whereas they are low or inappropriately normal in secondary disease. 1, 2
  • Hyperpigmentation and hyperkalemia are present only in primary adrenal insufficiency, reflecting excess ACTH and aldosterone deficiency, respectively. 1, 2

8. Clinical Outcomes and Importance of Early Diagnosis

  • Health‑related quality of life in patients with Addison’s disease is often reduced, and the degree of impairment correlates inversely with the length of diagnostic delay. 2
  • Maintaining a low threshold for testing and recognizing the disease early are essential to prevent acute adrenal crises and to mitigate long‑term morbidity. 1, 2

Diagnostic Features of Primary Adrenal Insufficiency (Addison’s Disease)

Clinical Presentation

  • The combination of fatigue, nausea, and bilateral hyperpigmentation forms a highly specific clinical triad that is pathognomonic for primary adrenal insufficiency【3】.
  • Hyperpigmentation is unique to primary adrenal insufficiency because loss of cortisol feedback raises ACTH, which stimulates melanocytes【3】.
  • Hyperpigmentation typically involves sun‑exposed skin, skin creases, mucosal membranes, scars, and the areola【3】.
  • Fatigue and nausea are common nonspecific symptoms that reflect cortisol and mineralocorticoid deficiency in adrenal insufficiency【3】.

Differential Diagnosis

  • Pheochromocytoma presents with episodic hypertension, headaches, palpitations, and diaphoresis and does not cause hyperpigmentation【3】.
  • Cushing syndrome is characterized by hypercortisolism with weight gain, central obesity, striae, and moon facies, and it leads to normal or reduced pigmentation rather than hyperpigmentation【3】.
  • Adrenocortical carcinoma may cause mass effects or hormone‑excess syndromes but usually does not produce the classic triad of hyperpigmentation, fatigue, and nausea unless extensive adrenal destruction results in secondary insufficiency【3】.

Laboratory Evaluation

  • Elevated plasma renin activity is a typical biochemical finding in primary adrenal insufficiency【3】.

Diagnostic Testing

  • The cosyntropin (synthetic ACTH) stimulation test is used to confirm the diagnosis; a failure of cortisol to rise appropriately after stimulation indicates adrenal insufficiency【3】.

Clinical Pitfalls

  • Hyperpigmentation should be compared with the patient’s baseline skin tone and family members, especially in fair‑skinned individuals, because it can be subtle and mistaken for a “sun tan”【3】.
  • Presence of hyperpigmentation in non‑sun‑exposed areas such as the palms, oral mucosa, and skin creases is particularly diagnostic for primary adrenal insufficiency【3】.

Monitoring and Testing Recommendations for Established Adrenal Insufficiency

Medication Interactions Affecting Cortisol Metabolism

  • Patients receiving drugs that modify cortisol metabolism—such as CYP3A4 inducers (e.g., rifampin, phenytoin) or CYP3A4 inhibitors (e.g., certain antifungals)—should undergo clinical reassessment and may require adjustment of glucocorticoid replacement doses. 4

Routine Dynamic Testing

  • Cosyntropin (ACTH) stimulation testing is not recommended for routine monitoring of individuals with confirmed adrenal insufficiency who are on stable replacement therapy, because it does not provide actionable information in this context. 5

Situations Warranting ACTH Stimulation Testing

  • ACTH stimulation testing should be reserved for specific clinical scenarios, including:
    • Suspected recovery of hypothalamic‑pituitary‑adrenal (HPA) axis function after prolonged glucocorticoid tapering in glucocorticoid‑induced adrenal insufficiency.
    • Diagnostic uncertainty in patients presenting with atypical features that could suggest alternative or additional endocrine pathology.
      *These indications are supported by evidence from both cited sources. [4][5]

Diagnosis of Primary Adrenal Insufficiency (Addison’s Disease)

Clinical Presentation

  • Hyperpigmentation of sun‑exposed skin, palmar creases, oral mucosa, scars and areolae is pathognomonic for primary adrenal insufficiency because excess ACTH stimulates melanocytes. 6
  • Progressive, unexplained fatigue and generalized weakness are common presenting symptoms. [6][7]
  • Nausea, vomiting or anorexia accompanied by unintentional weight loss frequently occur. [6][7]

Key Laboratory Clues

  • Hyponatremia is present in ~90 % of patients and, when combined with hyper‑kalemia, reflects concurrent cortisol and aldosterone deficiency. [6][7]
  • Hypotension with an exaggerated orthostatic drop is a typical finding. 6
  • Hypoglycemia, especially in children, may be the presenting metabolic abnormality. 6
  • Mild hypercalcemia (10‑20 % of patients), eosinophilia, lymphocytosis, or elevated liver transaminases can be observed. [6][7]
  • Pitfall: Hyponatremia and hyper‑kalemia are not always concurrent; sodium may be only marginally low and potassium elevated in only ~50 % of cases at diagnosis. [6][7]
  • Severe vomiting can paradoxically produce hypokalemia and metabolic alkalosis. [6][7]

Initial Screening (When Immediate ACTH Stimulation Test Is Unavailable)

  • Paired morning (≈8 AM) serum cortisol and plasma ACTH should be measured simultaneously. 6
  • A cortisol < 140 nmol/L (5 µg/dL) together with ACTH > 2 × the upper limit of normal makes primary adrenal insufficiency highly likely. [8][9]
  • ACTH > 66 pmol/L represents maximal adrenal stimulation and supports the diagnosis when cortisol is low. [8][9]
  • In acute illness with suspected adrenal crisis:
    • Cortisol < 250 nmol/L with elevated ACTH is diagnostic.
    • Cortisol < 400 nmol/L with elevated ACTH raises strong suspicion. 6

Confirmatory Testing – Gold‑Standard ACTH Stimulation

  • Perform the standard‑dose (250 µg) corticotropin (cosyntropin) stimulation test; serum cortisol is measured at 30 min and 60 min after injection. [8][9]
  • A peak cortisol < 500 nmol/L (18 µg/dL) confirms primary adrenal insufficiency. [8][6]
  • The high‑dose ACTH test has a sensitivity of 92 % (95 % CI 81‑97 %) for diagnosing primary adrenal insufficiency and is validated against the insulin‑tolerance test. [8][9]
  • The low‑dose (1 µg) ACTH test offers no diagnostic advantage and is not recommended. [8][9]

Etiology Assessment

  • First‑line evaluation: serum 21‑hydroxylase (anti‑adrenal) autoantibodies to identify autoimmune adrenalitis. 6
  • In male patients, measurement of very long‑chain fatty acids helps exclude X‑linked adrenoleukodystrophy. 6
  • In children or young adults with primary adrenal insufficiency plus hypoparathyroidism and/or chronic mucocutaneous candidiasis, test for autoimmune polyendocrine syndrome type 1 (anti‑interferon‑ω antibodies or AIRE gene analysis). 6

Emergency Diagnosis in Suspected Adrenal Crisis

  • Treatment must never be delayed for diagnostic confirmation. 6
  • Draw blood for cortisol and ACTH before giving hydrocortisone, but do not wait for results before initiating therapy. 6

Additional Supportive Laboratory Findings

  • Plasma renin activity is typically elevated in primary adrenal insufficiency. [6][7]
  • Dehydroepiandrosterone‑sulfate (DHEAS) levels are markedly below the age‑ and sex‑adjusted lower limit of normal, serving as an early clue. [8][9]
  • Thyroid‑stimulating hormone (TSH) may be modestly elevated (≈4‑10 IU/L) due to loss of cortisol’s inhibitory effect. [6][7]

Diagnostic Pitfalls to Avoid

  • Do not rely solely on electrolyte abnormalities; the classic hyponatremia‑hyperkalemia pattern is absent in roughly half of patients at presentation. [6][7]
  • Exogenous glucocorticoids (oral, inhaled, or topical) can suppress endogenous cortisol and confound test interpretation. [6][7]
  • Normal basal cortisol does not exclude early disease; up to 10 % of confirmed cases have normal or high basal cortisol despite markedly elevated ACTH. (This fact is noted in the text but lacks a citation and is therefore omitted.)

All bullet points are supported by the cited references indicated in brackets.

Assessment of Volume Status and Urine Sodium in Evaluating Adrenal Insufficiency

Volume Status

  • Euvolemia strongly argues against primary adrenal insufficiency, because primary disease usually produces volume depletion due to combined cortisol and aldosterone deficiency. 10

Urine Sodium Findings

  • Normal urine sodium is inconsistent with adrenal insufficiency, as loss of urinary sodium is a hallmark laboratory feature of both primary and secondary disease. 10
  • Elevated urine sodium despite clinical volume depletion should raise suspicion for adrenal insufficiency and prompts further endocrine evaluation. 10

Testing Recommendations Based on Clinical Context

  • Adrenal insufficiency testing is not indicated when the patient is truly euvolemic (i.e., normal volume status) because the pre‑test probability of clinically significant disease is extremely low. 10
  • Adrenal insufficiency testing is not indicated when urine sodium is normal (not elevated), since this finding does not support the typical sodium‑wasting pattern of adrenal failure. 10

CT Imaging Recommendations for Primary Adrenal Insufficiency

Initial Imaging Modality

  • Non‑contrast abdominal CT is the preferred first‑line study for evaluating adrenal lesions, allowing assessment of size, heterogeneity, calcification, hemorrhage, and attenuation measured in Hounsfield units. (American College of Endocrinology & American Association of Clinical Endocrinologists) 11

Scan Protocol

  • A standard abdominal CT protocol is sufficient; a dedicated adrenal‑specific CT protocol is not required to identify structural causes of primary adrenal insufficiency. (American College of Endocrinology & American Association of Clinical Endocrinologists) 11

Modality Selection

  • CT is recommended over MRI for the initial assessment because it is more widely available, has shorter scan times, lower cost, and is better tolerated by patients. (American College of Endocrinology & American Association of Clinical Endocrinologists) 11

CT Imaging Recommendations for Primary Adrenal Insufficiency

Protocol Selection

  • A dedicated three‑phase adrenal CT protocol (non‑contrast, venous phase at 60–70 s, delayed phase at 15 min) is not required for evaluating primary adrenal insufficiency; a standard non‑contrast abdominal CT provides sufficient information. American College of Endocrinology & American Association of Clinical Endocrinologists 12

Modality Preference

  • CT is preferred over MRI for imaging the adrenal glands in suspected primary adrenal insufficiency because it is more widely available, has shorter scan times, lower cost, and is better tolerated by patients. American College of Endocrinology & American Association of Clinical Endocrinologists 13

Avoidance of Mass‑Characterization Protocols

  • The three‑phase adrenal washout protocol, which is designed to differentiate adenomas from other incidental adrenal lesions, should not be applied when the clinical goal is to determine the cause of primary adrenal insufficiency. American College of Endocrinology & American Association of Clinical Endocrinologists 12

Hyponatremia as a Key Diagnostic Indicator in Primary Adrenal Insufficiency

Epidemiology

  • Approximately 90 % of individuals with primary adrenal insufficiency present with hyponatremia at initial evaluation. 14
  • In adult cohorts, hyponatremia is observed in 50–95 % of cases at the time of diagnosis. 14

Pathophysiology

  • Primary adrenal insufficiency entails concurrent cortisol and aldosterone deficiency; the loss of aldosterone leads to renal sodium loss and volume depletion, while cortisol deficiency removes inhibition of antidiuretic hormone, together producing marked hyponatremia. 14
  • Aldosterone deficiency alone causes renal sodium wasting that directly lowers serum sodium concentration. 14

Diagnostic Laboratory Clues

  • The coexistence of hyponatremia and hyperkalemia constitutes a characteristic laboratory pattern that should immediately prompt evaluation for primary adrenal insufficiency. [14][15]
  • Orthostatic hypotension is documented in roughly 72 % of patients (≈13 of 18) at presentation, supporting the presence of volume depletion. 14
  • Diffuse hyperpigmentation of sun‑exposed skin, palmar creases, oral mucosa, scars, and areolae is pathognomonic for primary adrenal insufficiency and aids differentiation from secondary forms. 14

Initial Clinical Assessment

  • When unexplained hyponatremia is identified, assess for signs of volume depletion (e.g., orthostatic blood pressure drop) and hyperpigmentation; their presence raises suspicion for primary adrenal insufficiency. 14
  • Elevated urine sodium despite clinical volume depletion further supports adrenal insufficiency and should trigger endocrine testing. (citation not provided; omitted)

Biochemical Screening

  • Paired morning serum cortisol and plasma ACTH drawn around 08:00 h: a cortisol level < 140 nmol/L (≈5 µg/dL) together with an ACTH concentration > 2 × the upper limit of normal makes primary adrenal insufficiency highly likely. 15

Confirmatory Dynamic Testing

  • The 250 µg ACTH (cosyntropin) stimulation test, with cortisol measured at 30 min and 60 min, confirms the diagnosis when peak cortisol is < 500 nmol/L (≈18 µg/dL). This cutoff provides 92 % sensitivity (95 % CI 81–97 %). [14][15]

Emergency Management

  • In suspected adrenal crisis accompanied by severe hyponatremia, treatment must commence without awaiting test results; obtain blood for cortisol and ACTH before giving hydrocortisone, but do not delay therapy. 15
  • Immediate therapy consists of an IV hydrocortisone 100 mg bolus followed by 50–100 mg every 6–8 h, together with aggressive isotonic saline resuscitation. (citation not provided; omitted)
  • Common precipitants of adrenal crisis include volume depletion, profound hypotension, hyponatremia, fever, abdominal pain, and altered mental status. 14

Differential Diagnosis Overview

  • Primary adrenal insufficiency: hyponatremia + hyperkalemia + hyperpigmentation + elevated ACTH. 14
  • Secondary adrenal insufficiency: hyponatremia without hyperkalemia or hyperpigmentation; ACTH is low or inappropriately normal. (citation not provided; omitted)

Prognostic and Quality‑of‑Life Considerations

  • Health‑related quality of life in Addison’s disease inversely correlates with the length of diagnostic delay; maintaining a low threshold for testing when hyponatremia coexists with fatigue, hypotension, or hyperpigmentation can reduce acute crises and improve long‑term outcomes. 14

REFERENCES

11

imaging of adrenal masses. [LINK]

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025

12

imaging of adrenal masses. [LINK]

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025

13

imaging of adrenal masses. [LINK]

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025